ASSOCIATION OF GLP-1 AGONISTS WITH ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN PATIENTS WITH TYPE 2 DIABETES: A META-ANALYSIS OF 27 RANDOMIZED CONTROLLED TRIALS

被引：0
|
作者：
Al-Sadawi, Mohammed [1 ]
Aslam, Faisal [1 ]
Aleem, Saadat [1 ]
Alsadaoee, Maryam [1 ]
Stevens, Gregg Alexander [1 ]
Singh, Abhijeet [1 ]
Almasry, Ibrahim O. [1 ]
Rashba, Eric J. [1 ]
Fan, Roger [1 ]
机构：
[1] Stony Brook Med, Stony Brook, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 79卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1525 / 1525
页数：1
相关论文
共 50 条
  • [41] GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
    Giugliano, Dario
    Scappaticcio, Lorenzo
    Longo, Miriam
    Caruso, Paola
    Maiorino, Maria Ida
    Bellastella, Giuseppe
    Ceriello, Antonio
    Chiodini, Paolo
    Esposito, Katherine
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [42] Effect of GLP-1 receptor agonists on microvascular endpoints in type 2 diabetes: a systematic review and meta-analysis
    Avgerinos, I.
    Karagiannis, T.
    Malandris, K.
    Liakos, A.
    Mainou, M.
    Andreadis, P.
    Bekiari, E.
    Matthews, D. R.
    Tsapas, A.
    DIABETOLOGIA, 2018, 61 : S354 - S354
  • [43] GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs
    Dario Giugliano
    Lorenzo Scappaticcio
    Miriam Longo
    Paola Caruso
    Maria Ida Maiorino
    Giuseppe Bellastella
    Antonio Ceriello
    Paolo Chiodini
    Katherine Esposito
    Cardiovascular Diabetology, 20
  • [44] Treatment with GLP1 receptor agonists reduce serum CRP concentrations in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
    Mazidi, Mohsen
    Karimi, Ehsan
    Rezaie, Peyman
    Ferns, Gordon A.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (07) : 1237 - 1242
  • [45] GLP-1 Agonists: Improving the Future of Patients With Type 2 Diabetes
    Shubrook, Jay H.
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2011, 111 (02): : ESII - ES1
  • [46] Comparative effectiveness of glycemic control in patients with type 2 diabetes treated with GLP-1 receptor agonists: a network meta-analysis of placebo-controlled and active-comparator trials
    Orme, Michelle E.
    Hiep Nguyen
    Lu, Jackie Y.
    Thomas, Susan A.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2017, 10 : 111 - 122
  • [47] GLP-1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis including the REWIND and PIONEER 6 trials
    Giugliano, Dario
    Maiorino, Maria Ida
    Bellastella, Giuseppe
    Longo, Miriam
    Chiodini, Paolo
    Esposito, Katherine
    DIABETES OBESITY & METABOLISM, 2019, 21 (11): : 2576 - 2580
  • [48] Association between Glucagon-like peptide-1 receptor agonists and risk of Arrhythmias or Heart Failure among patients with Type 2 Diabetes: A Meta-Analysis of 29 Randomized Controlled Trials
    Jaiswal, Vikash
    Jaiswal, Akash
    Kalra, Kriti
    Danisha, Fnu
    Mattumpuram, Jishanth
    Biswas, Monodeep
    CIRCULATION, 2024, 150
  • [49] Type of arrhythmias and the risk of sudden cardiac death in dialysis patients: a systematic review and meta-analysis
    Chander, Subhash
    Aamir, Ahmad Bin
    Latif, Rabia
    Parkash, Om
    Sorath, F. N. U.
    Tan, Sam
    Lohana, Abhi Chand
    Shiwlani, Sheena
    Nadeem, Mohammed Yaqub
    EGYPTIAN HEART JOURNAL, 2025, 77 (01):
  • [50] Safety and efficacy of GLP-1 and glucagon receptor dual agonist for the treatment of type 2 diabetes and obesity: a systematic review and meta-analysis of randomized controlled trials
    Deng, Bixin
    Ruan, Tiechao
    Lu, Wenting
    Ying, Junjie
    Li, Shiping
    Zhou, Ruixi
    Mu, Dezhi
    ENDOCRINE, 2024, 86 (01) : 15 - 27
12345